SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Moseley & Co VI, LLC (Last) (First) (Middle) 4200 NORTHSIDE PARKWAY, N.W. BUILDING 9 (Street) ATLANTA GA 30327 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/16/2012	3. Issuer Name and Ticker or Trading Symbol STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Series A 0% Convertible Preferred Stock	08/16/2012	(1)	COMMON STOCK	986,854	0	I	SEE EXPLANATION OF RESPONSE BELOW
Warrants	02/17/2013	02/17/2018	COMMON STOCK	490,000	3.99	I	SEE EXPLANATION OF RESPONSE BELOW(2)(3)

1. Name and Address of Reporting Person* Moseley & Co VI, LLC (Last) (First) (Middle) 4200 NORTHSIDE PARKWAY, N.W. BUILDING 9 (Street) ATLANTA GA 30327 (City) (State) (Zip)

1. Name and Address of Reporting Person* NORO-MOSELEY PARTNERS VI, L.P. (Last) (First) (Middle) 4200 NORTHSIDE PARKWAY, N.W. BUILDING 9 (Street) ATLANTA GA 30327 (City) (State) (Zip)

Explanation of Responses:

1. The Series A 0% Convertible Preferred stock was acquired for $3.00 per share, is convertible at any time and has no expiration date.

2. This report is filed jointly by Noro-Moseley Partners VI, L.P. and its general partner, Moseley and Company VI, LLC.

3. The foregoing securities are owned directly by Noro-Moseley Partners VI, L.P. Moseley and Company VI, LLC may be deemed to beneficially own all of the foregoing securities.

	Allen Moseley, AS CLASS A MEMBER OF EACH REPORTING ENTITY	08/20/2012
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.